Pharmacogenetics and pharmacoepigenetics of gemcitabine

被引：24
作者：
Candelaria, M. [3 ]
de la Cruz-Hernandez, E. [2 ]
Perez-Cardenas, E. [2 ]
Trejo-Becerril, C. [2 ]
Gutierrez-Hernandez, O. [2 ]
Duenas-Gonzalez, A. [1 ]
机构：
[1] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unit Biomed Res Canc, Mexico City 04510, DF, Mexico
[2] Inst Nacl Cancerol INCan, Basic Res Div, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol INCan, Div Clin Res, Mexico City, DF, Mexico
来源：
MEDICAL ONCOLOGY | 2010年 / 27卷 / 04期
关键词：
Gemcitabine; Pharmacogenetics; Pharmacoepigenetics; Epigenetics; Antimetabolites; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-1; DEOXYCYTIDINE KINASE PROMOTER; MESSENGER-RNA EXPRESSION; REDUCED FOLATE CARRIER; RIBONUCLEOTIDE REDUCTASE; FUNCTIONAL-CHARACTERIZATION; DNA METHYLATION; MEMBRANE TRANSPORTERS; PRETREATED PATIENTS; CYTIDINE-DEAMINASE;
D O I：
10.1007/s12032-009-9349-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Gemcitabine (2',2'-difluoro 2'deoxycytidine, dFdC) is an analog of cytosine with distinctive pharmacological properties and a wide antitumor-activity spectrum. The pharmacological characteristics of gemcitabine are unique because two main classes of genes are essential for its antitumor effects: membrane transporter protein-coding genes, whose products are responsible for drug intracellular uptake, as well as enzyme-coding genes, which catalyze its activation and inactivation. The study of the pharmacogenetics and pharmacoepigenetics of these two gene classes is greatly required to optimize the drug's therapeutic use in cancer. This review aims to provide an update of genetic and epigenetic bases that may account for interindividual variation in therapeutic outcome exhibited by gemcitabine.
引用
收藏
页码：1133 / 1143
页数：11
相关论文
共 99 条
[1]   Characterization and functional analysis of the promoter for the human equilibrative nucleoside transporter gene, hENT1 [J].
Abdulla, Parween ;
Coe, Imogen R. .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2007, 26 (01) :99-110
[2]   Determinants of sensitivity and resistance to gemcitabine: The roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer [J].
Achiwa, H ;
Oguri, T ;
Sato, S ;
Maeda, H ;
Niimi, T ;
Ueda, R .
CANCER SCIENCE, 2004, 95 (09) :753-757
[3]   Decitabine (5-Aza-2′-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells [J].
Ando, T ;
Nishimura, M ;
Oka, Y .
LEUKEMIA, 2000, 14 (11) :1915-1920
[4]  
ANTONSSON BE, 1987, CANCER RES, V47, P3672
[5]   A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer [J].
Arce, Claudia ;
Perez-Plasencia, Carlos ;
Gonzalez-Fierro, Aurora ;
de la Cruz-Hernandez, Erick ;
Revilla-Vazquez, Alma ;
Chavez-Blanco, Alma ;
Trejo-Becerril, Catalina ;
Perez-Cardenas, Enrique ;
Taja-Chayeb, Lucia ;
Bargallo, Enrique ;
Villarreal, Patricia ;
Ramirez, Teresa ;
Vela, Teresa ;
Candelaria, Myrna ;
Camargo, Maria F. ;
Robles, Elizabeth ;
Duenas-Gonzalez, Alfonso .
PLOS ONE, 2006, 1 (01)
[6]  
AVRAMIS VI, 1989, CANCER CHEMOTH PHARM, V24, P203
[7]  
BADAGNANI I, 2005, PHARMACOGENOMICS J, V124, P505
[8]   Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes [J].
Baldwin, SA ;
Yao, SYM ;
Hyde, RJ ;
Ng, AML ;
Foppolo, S ;
Barnes, K ;
Ritzel, MWL ;
Cass, CE ;
Young, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (16) :15880-15887
[9]   Nucleoside transporters: molecular biology and implications for therapeutic development [J].
Baldwin, SA ;
Mackay, JR ;
Cass, CE ;
Young, JD .
MOLECULAR MEDICINE TODAY, 1999, 5 (05) :216-224
[10]   Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH [J].
Barnes, Kay ;
Dobrzynski, Halina ;
Foppolo, Sophie ;
Beal, Paul R. ;
Ismat, Fouzia ;
Scullion, Elspeth R. ;
Sun, Lijie ;
Tellez, James ;
Ritzel, Mabel W. L. ;
Claycomb, William C. ;
Cass, Carol E. ;
Young, James D. ;
Billeter-Clark, Rudi ;
Boyett, Mark R. ;
Baldwin, Stephen A. .
CIRCULATION RESEARCH, 2006, 99 (05) :510-519
12345678910